Literature DB >> 12451294

Simultaneous and rapid analysis of cyclosporin A and creatinine in finger prick blood samples using liquid chromatography tandem mass spectrometry and its application in C2 monitoring.

Brian G Keevil1, David P Tierney, Donald P Cooper, Michael R Morris, Ali Machaal, Nizar Yonan.   

Abstract

A simple and rapid liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the simultaneous analysis of cyclosporin A (CsA) and creatinine using capillary blood has been developed. Venous and capillary blood samples were taken predose and at C2 from 65 heart and lung transplant recipients (65 x 4 samples). For comparisons, serum creatinine and blood CsA concentrations were measured by the Jaffe and EMIT methods, respectively, using an Olympus AU600 analyzer. For the LC-MS/MS assay, samples were prepared in a 96 x 700-microL well block by adding 10 microL of blood (or serum) to 40 microL of 0.1 mol/L zinc sulphate solution containing deuterated creatinine internal standard. Proteins were precipitated by adding 100 microL acetonitrile containing ascomycin internal standard. After vigorous mixing and centrifugation, 5 microL of the supernatant was injected into the LC-MS/MS system. A Waters 2795 high-performance liquid chromatography (HPLC) system was used to elute a C18 cartridge (3 mm x 4 mm) at 0.6 mL/min with a step gradient of 50-100% methanol containing 2 mmol/L ammonium acetate and 0.1% (v/v) formic acid. The column was maintained at 55 degrees C, and the retention times were creatinine, 0.4 minutes; ascomycin, 0.98 minutes; and CsA, 1.2 minutes. Cycle time was 2.5 minutes, injection to injection. The analytes were monitored using a Quattro microtandem mass spectrometer operated in multiple reaction monitoring mode using the following transitions: creatinine, m/z 114>44; d3-creatinine (IS), m/z 117>47; ascomycin (IS), m/z 809>756; and CsA, m/z 1,220>1,203. Assay characteristics were CsA intraassay CV, 3.6-3.0% (33-1,500 microg/L); CsA interassay CV, 6.7-2.5% (10-5,000 microg/L); LC-MS/MS capillary [CsA] = 0.99 x LC-MS/MS venous [CsA] - 4.2, R = 0.98; and LC-MS/MS venous [CsA] = 0.93 x EMIT venous [CsA] + 2.9, R = 0.98. Creatinine intraassay CV, 6.6-2.5% (20-720 micromol/L); interassay CV, 5.7-3.3% (80-590 micromol/L); LC-MS/MS capillary [creatinine] = 0.99 Jaffe plasma [creatinine] -42.6, R = 0.87. Total time for the preparation and analysis of 30 samples was approximately 2 hours. This assay will provide a flexible, robust, and cost-effective solution for the monitoring of CsA and creatinine in transplant recipients with potential applications in pediatric medicine and pharmacokinetic studies, in which frequent sampling is required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451294     DOI: 10.1097/00007691-200212000-00013

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  8 in total

1.  Comment on "Home fingerprick sampling for immunosuppressant drug monitoring in pediatric renal transplant recipients".

Authors:  Pleasant F Hooper; Thomas D Dreesen; Brian G Keevil; Sander Florman
Journal:  Nat Clin Pract Nephrol       Date:  2009-03

2.  Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry.

Authors:  Dennis R Koop; Lisa A Bleyle; Myrna Munar; Ganesh Cherala; Amira Al-Uzri
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-03-04       Impact factor: 3.205

Review 3.  Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.

Authors:  Mwlod Ghareeb; Fatemeh Akhlaghi
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

4.  Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS.

Authors:  Touraj Shokati; Nicholas Bodenberger; Holly Gadpaille; Björn Schniedewind; Alexander A Vinks; Wenlei Jiang; Rita R Alloway; Uwe Christians
Journal:  J Vis Exp       Date:  2015-11-08       Impact factor: 1.355

5.  Potential of dried blood self-sampling for cyclosporine c(2) monitoring in transplant outpatients.

Authors:  Alexander Benedikt Leichtle; Uta Ceglarek; Helmut Witzigmann; Gábor Gäbel; Joachim Thiery; Georg Martin Fiedler
Journal:  J Transplant       Date:  2010-06-27

6.  Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis.

Authors:  Nicholas J A Webb; Malcolm G Coulthard; Richard S Trompeter; Margaret M Fitzpatrick; Suzanne Stephens; Jan Dudley; Heather Maxwell; Simon Waller; Graham C Smith; Alan R Watson; David A Hughes; Brian G Keevil; Janice S Ellis
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

7.  Rapid genotyping of single nucleotide polymorphisms influencing warfarin drug response by surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) mass spectrometry.

Authors:  Shangbin Yang; LiHui Xu; Haifeng M Wu
Journal:  J Mol Diagn       Date:  2010-01-14       Impact factor: 5.568

8.  Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS.

Authors:  Mustafa Karapirli; Murat Kizilgun; Ozgur Yesilyurt; Husamettin Gul; Zeki Ilker Kunak; Emin Ozgur Akgul; Enis Macit; Tuncer Cayci; Yasemin Gulcan Kurt; Ibrahim Aydin; Hakan Yaren; Melik Seyrek; Erdinc Cakir; Halil Yaman
Journal:  ScientificWorldJournal       Date:  2012-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.